Funding for this research was provided by:
National Natural Science Foundation of China (81673555)
Double First Class University Plan (CPU2018GY32, CPU2018GF06)
Received: 27 February 2020
Accepted: 12 May 2020
First Online: 20 May 2020
Ethics approval and consent to participate
: The study protocol and experiments were approved by the Animal Ethics Committee of China Pharmaceutical University, China Pharmaceutical University, Nanjing, Jiangsu, China.
: Not applicable.
: The authors declare that they have no competing interests.